Microvast Q3 Revenue Falls 63%; Going-Concern Doubt Remains
The net loss widened to $76.8 million in the quarter, and the company says its available cash may not cover obligations over the next twelve months.
Stock reaction: MVST shares closed down 64.4% at $0.22 on Nov. 10, from Nov. 9's close of $0.62. The S&P 500 was down 0.4% that day.

Key points
- Q3 2026 revenue fell 62.8% to $45.8 million from $123.3 million
- Net loss was $76.8 million vs. $1.5 million a year earlier, including $35.7 million in impairments
- Convertible bonds of $41.7 million are due by Jan. 31, 2027
- Cash of $124.4 million at Sept. 30; usable cash about $71.3 million as of Oct. 31
- Going-concern substantial doubt has not been alleviated, the company said
Microvast Holdings Inc. (Nasdaq: MVST) reported a steep drop in third-quarter sales and said its cash may not cover obligations over the next twelve months, in an 8-K filed Monday, Nov. 9, 2026. The filing furnishes unaudited results for the quarter ended Sept. 30, along with a press release and a slideshow.
Before the filing, the stock closed at $0.62 on Nov. 9, giving the company a market value of about $238.4 million, based on 384.5 million shares as of Aug. 3. A separate 8-K filed Aug. 31 was listed under Item 3.01, which covers delisting notices and failure to meet listing standards.
Sales fell and margins were squeezed
Revenue was $45.8 million in the quarter, down 62.8% from $123.3 million a year earlier. Sales volume fell 62.2%, to about 189.6 megawatt-hours from 501.7. The company attributed the decline to weaker demand in Europe and Asia-Pacific for heavy-duty trucks, port equipment and mining equipment.
Gross margin fell to 5.2% from 37.6%. A $9.3 million write-down for obsolete inventory accounted for 20.4 percentage points of that decline.
A wider loss and impairment charges
The net loss was $76.8 million, compared with $1.5 million a year earlier, a much wider loss. Operating expenses rose to $69.0 million from $31.6 million, driven by $35.7 million in non-cash impairment charges on long-lived assets, including $15.0 million in China, $4.4 million in Germany and $16.3 million in the U.S.
For the nine months, the net loss narrowed to $40.6 million from $45.8 million. The company cited a $58.0 million non-cash gain from changes in the fair value of its warrant and convertible loan. Cash, cash equivalents and restricted cash were $124.4 million at Sept. 30, down from $169.2 million at Dec. 31, 2025. Net cash used in operating activities was $65.4 million for the nine months.
Debt maturities and going-concern doubt
Total debt was $177.0 million at Sept. 30. Near-term obligations include $41.7 million of convertible bonds due, with accrued interest, on or before Jan. 31, 2027, and $84.0 million of short-term bank loans at its Chinese subsidiaries. The company said a missed payment would be an event of default and could accelerate substantially all of its bank borrowings and bonds.
As of Oct. 31, usable cash across all entities was about $71.3 million. The company said it cannot currently move cash from China and Europe to fund U.S. operations. Management said that, absent financing, refinancing or further cost cuts, available cash will be insufficient to meet obligations over the next twelve months. It concluded that substantial doubt about the company's ability to continue as a going concern has not been alleviated.
What comes next
Microvast is negotiating with its lenders to refinance, extend or restructure its near-term debt, but said there can be no assurance of acceptable terms. It is cutting costs, reducing or deferring capital spending and reducing staff in some operations. Installation of Phase 3.2 equipment at Huzhou, China, is complete, and the company said it will run below design capacity unless volumes rise. Full-scale construction at Clarksville remains contingent on additional financing or strategic partnerships.
Management will hold a conference call and webcast on Nov. 9 at 4:00 p.m. Central Time.
Sources
Written with AI from the company's SEC filing and our market data, and checked against those sources before publishing. Our editorial standards.
More SEC filing stories
Latest earnings results →- GoPro Delays Q3 10-Q, Discloses Preliminary Revenue of About $96 Million · GPRO · Nov. 10, 2026
- Mercer International to Exchange $1.275 Billion of Notes for Equity Through Chapter 11 · MERC · Nov. 10, 2026
- SHF Holdings Reports Q3 Loss and Outlines Nonbinding Opifex Merger Term Sheet · SHFS · Nov. 9, 2026
- Heron Therapeutics Reports $35.3 Million Q3 Revenue and Agrees to Sell Its Assets · HRTX · Nov. 9, 2026
More on Microvast
MVST page →Filings, figures and price history are on the Microvast page.